<?xml version="1.0"?><rss version="2.0">
 <channel>
  <title>StreetInsider.com News Articles</title>
  <link>http://www.streetinsider.com</link>
  <description>Latest StreetInsider.com News Articles</description>
  <language>en-us</language>
  <copyright>Copyright 2022, StreetInsider.com</copyright>
  <managingEditor>rss@streetinsider.com (SI RSS)</managingEditor>
  <webMaster>rss@streetinsider.com (SI RSS)</webMaster>
  <lastBuildDate>Tue, 09 Mar 2021 07:10:00 -0400</lastBuildDate>
  <docs>http://blogs.law.harvard.edu/tech/rss</docs>
  <image>
   <url>http://www.streetinsider.com/images/rss_logo.gif</url>
   <title>StreetInsider.com News Articles</title>
   <link>http://www.streetinsider.com</link>
   <width>143</width>
   <height>28</height>
  </image>
  <skipHours>
   <hour>0</hour>
   <hour>1</hour>
   <hour>2</hour>
   <hour>3</hour>
   <hour>21</hour>
   <hour>22</hour>
   <hour>23</hour>
  </skipHours>
  <skipDays>
   <day>Saturday</day>
   <day>Sunday</day>
  </skipDays>
  <item>
   <title>Apollomics, Inc. Appoints Seasoned Healthcare Executive K. Peony Yu, M.D., as Chief Medical Officer</title>
   <link>http://www.streetinsider.com/Press+Releases/Apollomics%2C+Inc.+Appoints+Seasoned+Healthcare+Executive+K.+Peony+Yu%2C+M.D.%2C+as+Chief+Medical+Officer/18098796.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Apollomics%2C+Inc.+Appoints+Seasoned+Healthcare+Executive+K.+Peony+Yu%2C+M.D.%2C+as+Chief+Medical+Officer/18098796.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Apollomics%2C+Inc.+Appoints+Seasoned+Healthcare+Executive+K.+Peony+Yu%2C+M.D.%2C+as+Chief+Medical+Officer/18098796.html</guid>
   <pubDate>Tue, 09 Mar 2021 07:10:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ANSV</category>
   	  </item>
  <item>
   <title>Apollomics, Inc. Appoints Seasoned Healthcare Executive K. Peony Yu, M.D., as Chief Medical Officer</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Apollomics%2C+Inc.+Appoints+Seasoned+Healthcare+Executive+K.+Peony+Yu%2C+M.D.%2C+as+Chief+Medical+Officer/18098796.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/Apollomics%2C+Inc.+Appoints+Seasoned+Healthcare+Executive+K.+Peony+Yu%2C+M.D.%2C+as+Chief+Medical+Officer/18098796.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Apollomics%2C+Inc.+Appoints+Seasoned+Healthcare+Executive+K.+Peony+Yu%2C+M.D.%2C+as+Chief+Medical+Officer/18098796.html</guid>
   <pubDate>Tue, 09 Mar 2021 07:10:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ANSV</category>
   	  </item>
  <item>
   <title>Anesiva (ANSV) Announces Intent to Cease Operations and File Bankruptcy After Failed Merger with Arcion Therapeutics</title>
   <link>http://www.streetinsider.com/Corporate+News/Anesiva+%28ANSV%29+Announces+Intent+to+Cease+Operations+and+File+Bankruptcy+After+Failed+Merger+with+Arcion+Therapeutics/5213310.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Anesiva+%28ANSV%29+Announces+Intent+to+Cease+Operations+and+File+Bankruptcy+After+Failed+Merger+with+Arcion+Therapeutics/5213310.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Corporate+News/Anesiva+%28ANSV%29+Announces+Intent+to+Cease+Operations+and+File+Bankruptcy+After+Failed+Merger+with+Arcion+Therapeutics/5213310.html</guid>
   <pubDate>Thu, 31 Dec 2009 17:06:40 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ANSV</category>
   	  </item>
  <item>
   <title>Anesiva (ANSV) Sells Certain Zingo Injection System Rights to Powder Pharma and Lee's Pharma</title>
   <link>http://www.streetinsider.com/Corporate+News/Anesiva+%28ANSV%29+Sells+Certain+Zingo+Injection+System+Rights+to+Powder+Pharma+and+Lee%27s+Pharma/5172751.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Anesiva+%28ANSV%29+Sells+Certain+Zingo+Injection+System+Rights+to+Powder+Pharma+and+Lee%27s+Pharma/5172751.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Corporate+News/Anesiva+%28ANSV%29+Sells+Certain+Zingo+Injection+System+Rights+to+Powder+Pharma+and+Lee%27s+Pharma/5172751.html</guid>
   <pubDate>Wed, 09 Dec 2009 17:33:35 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ANSV</category>
   	  </item>
  <item>
   <title>Needham &amp; Co Downgrades Anesiva (ANSV) to Hold </title>
   <link>http://www.streetinsider.com/Downgrades/Needham+%26+Co+Downgrades+Anesiva+%28ANSV%29+to+Hold+/4290313.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Downgrades/Needham+%26+Co+Downgrades+Anesiva+%28ANSV%29+to+Hold+/4290313.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Downgrades/Needham+%26+Co+Downgrades+Anesiva+%28ANSV%29+to+Hold+/4290313.html</guid>
   <pubDate>Fri, 09 Jan 2009 09:52:09 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ANSV</category>
   	  </item>
  <item>
   <title>Anesiva (ANSV) Announces FDA Approval of sNDA to Expand Zingo(TM) Indication to Include Adults</title>
   <link>http://www.streetinsider.com/Corporate+News/Anesiva+%28ANSV%29+Announces+FDA+Approval+of+sNDA+to+Expand+Zingo%28TM%29+Indication+to+Include+Adults/4290300.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Anesiva+%28ANSV%29+Announces+FDA+Approval+of+sNDA+to+Expand+Zingo%28TM%29+Indication+to+Include+Adults/4290300.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Corporate+News/Anesiva+%28ANSV%29+Announces+FDA+Approval+of+sNDA+to+Expand+Zingo%28TM%29+Indication+to+Include+Adults/4290300.html</guid>
   <pubDate>Fri, 09 Jan 2009 09:48:26 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ANSV</category>
   	  </item>
  <item>
   <title>Anesiva (ANSV) Announces FDA Approval of sNDA to Expand Zingo(TM) Indication to Include Adults</title>
   <link>http://www.streetinsider.com/FDA/Anesiva+%28ANSV%29+Announces+FDA+Approval+of+sNDA+to+Expand+Zingo%28TM%29+Indication+to+Include+Adults/4290300.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/FDA/Anesiva+%28ANSV%29+Announces+FDA+Approval+of+sNDA+to+Expand+Zingo%28TM%29+Indication+to+Include+Adults/4290300.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/FDA/Anesiva+%28ANSV%29+Announces+FDA+Approval+of+sNDA+to+Expand+Zingo%28TM%29+Indication+to+Include+Adults/4290300.html</guid>
   <pubDate>Fri, 09 Jan 2009 09:48:26 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ANSV</category>
   	  </item>
  <item>
   <title>Anesiva (ANSV) Announces ACTIVE-1 Phase 3 Trial Evaluating Adlea Missed Primary Endpoint; Ceases Certain Operations and Delays Earnings Release</title>
   <link>http://www.streetinsider.com/Corporate+News/Anesiva+%28ANSV%29+Announces+ACTIVE-1+Phase+3+Trial+Evaluating+Adlea+Missed+Primary+Endpoint%3B+Ceases+Certain+Operations+and+Delays+Earnings+Release/4145906.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Anesiva+%28ANSV%29+Announces+ACTIVE-1+Phase+3+Trial+Evaluating+Adlea+Missed+Primary+Endpoint%3B+Ceases+Certain+Operations+and+Delays+Earnings+Release/4145906.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Corporate+News/Anesiva+%28ANSV%29+Announces+ACTIVE-1+Phase+3+Trial+Evaluating+Adlea+Missed+Primary+Endpoint%3B+Ceases+Certain+Operations+and+Delays+Earnings+Release/4145906.html</guid>
   <pubDate>Mon, 10 Nov 2008 17:05:01 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ANSV</category>
   	  </item>
  <item>
   <title>Anesiva (ANSV) Announces ACTIVE-1 Phase 3 Trial Evaluating Adlea Missed Primary Endpoint; Ceases Certain Operations and Delays Earnings Release</title>
   <link>http://www.streetinsider.com/Earnings/Anesiva+%28ANSV%29+Announces+ACTIVE-1+Phase+3+Trial+Evaluating+Adlea+Missed+Primary+Endpoint%3B+Ceases+Certain+Operations+and+Delays+Earnings+Release/4145906.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Anesiva+%28ANSV%29+Announces+ACTIVE-1+Phase+3+Trial+Evaluating+Adlea+Missed+Primary+Endpoint%3B+Ceases+Certain+Operations+and+Delays+Earnings+Release/4145906.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Earnings/Anesiva+%28ANSV%29+Announces+ACTIVE-1+Phase+3+Trial+Evaluating+Adlea+Missed+Primary+Endpoint%3B+Ceases+Certain+Operations+and+Delays+Earnings+Release/4145906.html</guid>
   <pubDate>Mon, 10 Nov 2008 17:05:01 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ANSV</category>
   	  </item>
  <item>
   <title>Anesiva (ANSV) to Restructure Operations In Order to Focus on Specialty Pharma Pain Management; Will Cut 20% of Workforce</title>
   <link>http://www.streetinsider.com/Corporate+News/Anesiva+%28ANSV%29+to+Restructure+Operations+In+Order+to+Focus+on+Specialty+Pharma+Pain+Management%3B+Will+Cut+20%25+of+Workforce/3958090.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Anesiva+%28ANSV%29+to+Restructure+Operations+In+Order+to+Focus+on+Specialty+Pharma+Pain+Management%3B+Will+Cut+20%25+of+Workforce/3958090.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Corporate+News/Anesiva+%28ANSV%29+to+Restructure+Operations+In+Order+to+Focus+on+Specialty+Pharma+Pain+Management%3B+Will+Cut+20%25+of+Workforce/3958090.html</guid>
   <pubDate>Wed, 03 Sep 2008 08:49:26 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ANSV</category>
   	  </item>
  <item>
   <title>Anesiva (ANSV) to Restructure Operations In Order to Focus on Specialty Pharma Pain Management; Will Cut 20% of Workforce</title>
   <link>http://www.streetinsider.com/Guidance/Anesiva+%28ANSV%29+to+Restructure+Operations+In+Order+to+Focus+on+Specialty+Pharma+Pain+Management%3B+Will+Cut+20%25+of+Workforce/3958090.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Guidance/Anesiva+%28ANSV%29+to+Restructure+Operations+In+Order+to+Focus+on+Specialty+Pharma+Pain+Management%3B+Will+Cut+20%25+of+Workforce/3958090.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Guidance/Anesiva+%28ANSV%29+to+Restructure+Operations+In+Order+to+Focus+on+Specialty+Pharma+Pain+Management%3B+Will+Cut+20%25+of+Workforce/3958090.html</guid>
   <pubDate>Wed, 03 Sep 2008 08:49:26 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ANSV</category>
   	  </item>
  <item>
   <title>Anesiva (ANSV) Names Kranda President/CEO</title>
   <link>http://www.streetinsider.com/Management+Changes/Anesiva+%28ANSV%29+Names+Kranda+PresidentCEO/3745611.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Management+Changes/Anesiva+%28ANSV%29+Names+Kranda+PresidentCEO/3745611.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Management+Changes/Anesiva+%28ANSV%29+Names+Kranda+PresidentCEO/3745611.html</guid>
   <pubDate>Mon, 16 Jun 2008 10:42:18 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ANSV</category>
   	  </item>
  <item>
   <title>Anesiva (ANSV) Receives FDA Acceptance of New Drug Application for Zingo</title>
   <link>http://www.streetinsider.com/FDA/Anesiva+%28ANSV%29+Receives+FDA+Acceptance+of+New+Drug+Application+for+Zingo/3674770.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/FDA/Anesiva+%28ANSV%29+Receives+FDA+Acceptance+of+New+Drug+Application+for+Zingo/3674770.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/FDA/Anesiva+%28ANSV%29+Receives+FDA+Acceptance+of+New+Drug+Application+for+Zingo/3674770.html</guid>
   <pubDate>Wed, 21 May 2008 07:52:01 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ANSV</category>
   	  </item>
  <item>
   <title>Anesiva (ANSV) Chief Financial Officer To Resign</title>
   <link>http://www.streetinsider.com/Management+Changes/Anesiva+%28ANSV%29+Chief+Financial+Officer+To+Resign/3346162.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Management+Changes/Anesiva+%28ANSV%29+Chief+Financial+Officer+To+Resign/3346162.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Management+Changes/Anesiva+%28ANSV%29+Chief+Financial+Officer+To+Resign/3346162.html</guid>
   <pubDate>Mon, 11 Feb 2008 16:55:51 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ANSV</category>
   	  </item>
 </channel>
</rss>
